SHALLAK, MARIAM
SHALLAK, MARIAM
DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA
A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line
2022-01-01 Pilotti, E.; Cannata, A.; Magnani, G.; Bignami, F.; Corsi, A.; Valenti, M. T.; Shallak, M.; Forlani, G.; Romanelli, M. G.
A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells
2024-01-01 Alberio, T.; Shallak, M.; Shaik, A. K. B.; Accolla, R. S.; Forlani, G.
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma
2024-01-01 Reale, Alberto; Gatta, Andrea; Shaik, Amruth Kaleem Basha; Shallak, Mariam; Chiaravalli, Anna Maria; Cerati, Michele; Zaccaria, Martina; La Rosa, Stefano; Calistri, Arianna; Accolla, Roberto Sergio; Forlani, Greta
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia
2021-01-01 Forlani, Greta; Shallak, Mariam; Tedeschi, Alessandra; Cavallari, Ilaria; Marçais, Ambroise; Hermine, Olivier; Accolla, Roberto S
HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity
2021-01-01 Accolla, Roberto S.; Forlani, Greta; Shallak, Mariam
Htlv-1 infection and pathogenesis: New insights from cellular and animal models
2021-01-01 Forlani, G.; Shallak, M.; Accolla, R. S.; Romanelli, M. G.
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma
2022-01-01 Gatta, A; Celesti, F; Chiaravalli, Am; Cerati, M; Shallak, M; Tedeschi, A; Sessa, F; Accolla, Rs; Forlani, G
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
2023-01-01 Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Maurino, V.; Baj, A.; Gianfagna, F.; Cavallo, P.; Dentali, F.; Tettamanti, L.; Maggi, F.; Maffioli, L. S.; Tagliabue, A.; Accolla, R. S.; Forlani, G.
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
2022-01-01 Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Ietto, G.; Iovino, D.; Baj, A.; Gianfagna, F.; Maurino, V.; Focosi, D.; Maggi, F.; Ferrario, M. M.; Dentali, F.; Carcano, G.; Tagliabue, A.; Maffioli, L. S.; Accolla, R. S.; Forlani, G.
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma
2024-01-01 Azzi, L.; Celesti, F.; Chiaravalli, A. M.; Shaik, A. K. B.; Shallak, M.; Gatta, A.; Battaglia, P.; La Rosa, S.; Tagliabue, A.; Accolla, R. S.; Forlani, G.
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
2023-01-01 Celesti, F.; Gatta, A.; Shallak, M.; Chiaravalli, A. M.; Cerati, M.; Sessa, F.; Accolla, R. S.; Forlani, G.
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
2019-01-01 Forlani, G.; Shallak, M.; Ramia, E.; Tedeschi, A.; Accolla, R. S.
The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing
2022-01-01 Shallak, M.; Alberio, T.; Fasano, M.; Monti, M.; Iacobucci, I.; Ladet, J.; Mortreux, F.; Accolla, R. S.; Forlani, G.
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
2023-01-01 Forlani, G.; Shallak, M.; Gatta, A.; Shaik, A. K. B.; Accolla, R. S.
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells
2022-01-01 Celesti, F; Azzi, L; Shallak, M; Gatta, A; Accolla, Rs; Forlani, G
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells
2020-01-01 Forlani, G.; Shallak, M.; Celesti, F.; Accolla, R. S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line | 1-gen-2022 | Pilotti, E.; Cannata, A.; Magnani, G.; Bignami, F.; Corsi, A.; Valenti, M. T.; Shallak, M.; Forlani, G.; Romanelli, M. G. | |
| A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells | 1-gen-2024 | Alberio, T.; Shallak, M.; Shaik, A. K. B.; Accolla, R. S.; Forlani, G. | |
| An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma | 1-gen-2024 | Reale, Alberto; Gatta, Andrea; Shaik, Amruth Kaleem Basha; Shallak, Mariam; Chiaravalli, Anna Maria; Cerati, Michele; Zaccaria, Martina; La Rosa, Stefano; Calistri, Arianna; Accolla, Roberto Sergio; Forlani, Greta | |
| Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia | 1-gen-2021 | Forlani, Greta; Shallak, Mariam; Tedeschi, Alessandra; Cavallari, Ilaria; Marçais, Ambroise; Hermine, Olivier; Accolla, Roberto S | |
| HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity | 1-gen-2021 | Accolla, Roberto S.; Forlani, Greta; Shallak, Mariam | |
| Htlv-1 infection and pathogenesis: New insights from cellular and animal models | 1-gen-2021 | Forlani, G.; Shallak, M.; Accolla, R. S.; Romanelli, M. G. | |
| Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma | 1-gen-2022 | Gatta, A; Celesti, F; Chiaravalli, Am; Cerati, M; Shallak, M; Tedeschi, A; Sessa, F; Accolla, Rs; Forlani, G | |
| Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine | 1-gen-2023 | Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Maurino, V.; Baj, A.; Gianfagna, F.; Cavallo, P.; Dentali, F.; Tettamanti, L.; Maggi, F.; Maffioli, L. S.; Tagliabue, A.; Accolla, R. S.; Forlani, G. | |
| Mucosal immune response in BNT162b2 COVID-19 vaccine recipients | 1-gen-2022 | Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Ietto, G.; Iovino, D.; Baj, A.; Gianfagna, F.; Maurino, V.; Focosi, D.; Maggi, F.; Ferrario, M. M.; Dentali, F.; Carcano, G.; Tagliabue, A.; Maffioli, L. S.; Accolla, R. S.; Forlani, G. | |
| Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma | 1-gen-2024 | Azzi, L.; Celesti, F.; Chiaravalli, A. M.; Shaik, A. K. B.; Shallak, M.; Gatta, A.; Battaglia, P.; La Rosa, S.; Tagliabue, A.; Accolla, R. S.; Forlani, G. | |
| Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA | 1-gen-2023 | Celesti, F.; Gatta, A.; Shallak, M.; Chiaravalli, A. M.; Cerati, M.; Sessa, F.; Accolla, R. S.; Forlani, G. | |
| Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 | 1-gen-2019 | Forlani, G.; Shallak, M.; Ramia, E.; Tedeschi, A.; Accolla, R. S. | |
| The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing | 1-gen-2022 | Shallak, M.; Alberio, T.; Fasano, M.; Monti, M.; Iacobucci, I.; Ladet, J.; Mortreux, F.; Accolla, R. S.; Forlani, G. | |
| The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy | 1-gen-2023 | Forlani, G.; Shallak, M.; Gatta, A.; Shaik, A. K. B.; Accolla, R. S. | |
| Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells | 1-gen-2022 | Celesti, F; Azzi, L; Shallak, M; Gatta, A; Accolla, Rs; Forlani, G | |
| Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells | 1-gen-2020 | Forlani, G.; Shallak, M.; Celesti, F.; Accolla, R. S. |